Why Become an Oncologist? With Dr Gregory Nalesnik

*The translation of this article in French and Portuguese has been made through machine translation and has not been edited yet. we apologise for any inaccuracies.

The pursuit of becoming an oncologist is not an easy one. The journey is long and can be filled with challenges; academic, clinical, and personal ones. So why become an oncologist? Is it worth your time and energy? Read what Dr Gregory Nalesnik has to say in this interview article.

Author picture

Visit Dr Gregory Nalesnik’s M3 Ambassador profile to join him on the M3 oncology panel.

Visit Dr Gregory Nalesnik M3 Ambassador Profile

Dr Gregory Nalesnik is a physician working at the Penn State Children’s Hospital in the United States, specialising in the field of Paediatric Haematology Oncology. With over five years of medical practice, active research involvement in high-risk leukaemia drug discovery and metabolic pathways of chemotherapy resistance, he is a valuable M3 Ambassador and a prominent figure in his medical field.

Dr Nalesnik’s career path is defined by dedication and a commitment to making a difference in the lives of cancer patients. His journey to becoming an oncologist is rooted in personal experiences and a strong sense of duty.

Since high school, Dr Nalesnik dreamed of becoming a doctor. His aspiration was fuelled by his parents, both cancer survivors, which instilled a deep sense of obligation to pursue a career in oncology. This familial connection became the cornerstone of his dedication to helping others in similar situations.

“Since high school, I always dreamed of becoming a doctor. My initial inspiration was derived from my parents, who are both cancer survivors. I felt a deep obligation to pursue the field of oncology and help others who are affected by cancer.”

Dr Gregory Nalesnik - oncologist

The Challenges and Rewards of Becoming an Oncologist

The field of oncology presents unique challenges and complex cases which often require interdisciplinary collaboration. Dr Nalesnik regularly participates in conferences that bring together professionals from diverse disciplines including oncology, surgery, neurosurgery, pathology, radiology, nuclear medicine, and more. These gatherings often involve over 50 participants, each with varying perspectives and opinions. Although challenging, these collaborations are exciting and bring forth ideas and strategies for the best possible outcome for cancer patients.

Within the ever-evolving landscape of haematology and oncology, Dr Nalesnik remains attentive to notable developments. He finds particular interest in the ongoing advancements in bone marrow transplants, CAR-T therapy, and proton radiation. These advancements offer new hope, even in cases with previously poor outcomes.

In his clinical practice, Dr Nalesnik sees himself as a “bedside clinician”. He takes great satisfaction in forming meaningful relationships with his patients and their families. The humanistic aspect of medicine is the most fulfilling part of his job. His involvement in oncology drug discovery research and clinical trials extends his commitment to providing hope for new therapies and treating patients, particularly those with aggressive cancers.

“I love developing relationships with my patients and their families. The humanistic aspect of medicine is by far the most fulfilling part of my job.”

why become an oncologist

Why do Oncologists Take Part in Healthcare Market Research with M3?

Beyond clinical practice, Dr Nalesnik takes part in healthcare market research with M3 Global Research. His involvement provides a unique opportunity to express opinions on current medical developments while receiving compensation.

Participating in market research keeps him updated and informed about advancements and trends in healthcare and oncology. For instance, he recently gained insights into the efforts of pharmaceutical companies in areas such as vaccine-preventable illnesses, cancer, and HIV.

For fellow physicians considering involvement in healthcare market research with M3, Dr Nalesnik offers enthusiastic encouragement. He highly recommends the experience, highlighting the tailored nature of the paid surveys to one’s specialty, ensuring relevance and value to their career interests.

Reflecting on his journey, Dr Nalesnik leaves us with a final message of persistence and dedication, urging aspiring physicians to never give up.

The process of becoming an oncologist is a long journey. There will be many setbacks and failures along the way, but I would encourage you to never give up. Having the privilege of treating these incredible patients makes the many years of training and study worthwhile. As Dr Tinsley Harrison famously said:

“No greater opportunity, responsibility, or obligation can fall to the lot of a human being than to become a physician. In the care of the suffering, he needs technical skills, scientific knowledge, and human understanding. He who uses these with courage, with humility, and with wisdom, will provide a unique service for his fellow man and will build an enduring edifice of character within himself. The physician should ask of his destiny no more than this, he should be content with no less.” ”

Did you find this article about Dr Gregory Nalesnik’s journey to becoming an oncologist informative and useful? Please share your thoughts in the comments section below and forward the article to a colleague in the field of oncology via social media:

Are you looking to optimise your physician career?

Be part of the M3 Panel and get rewarded when you share your opinions in paid market research studies


  1. If you had been my first Oncologist, I would not have had to leave you for the patient-centered treatment plan I want for my cancer journey. It was profitably over patient care.
    Thankfully my current Oncologist understands me and possesses the same physician character traits mentioned in your article.
    I am at 17th months of remission (S4 MPC) and feeling better than ever.

Leave a Reply

Join Today

Registration is free and only takes a few clicks

Panel Members

Check your available studies

latest posts

emerging respiratory treatments for lung cancer - cystic fibrosis - robotic navigation - gene-editing nanoparticles

Emerging Respiratory Treatments: Frontiers in Pulmonology

Emerging respiratory medicines and treatments, including robotic navigation and gene-editing nanoparticles, may significantly improve patient outcomes in the future for prevalent pulmonary diseases like lung cancer, cystic fibrosis, and chronic obstructive pulmonary disease.

Paid Studies About Medical Devices | M3 Guide

Real-World Evidence studies collect real-world data to evaluate the safety and performance of medical devices. This M3 Guide reveals how we conduct Real-World Evidence studies, how they contribute to better patient outcomes, and how healthcare professionals can get compensated.